FDA Authorizes New Long-Acting Monoclonal Antibodies (AZD7442 or EVUSHELD) for Pre-Exposure Prevention of COVID-19 in Certain Individuals
There is reason to believe the shots could be available very quickly, maybe even later this month. What a Christmas present that would be!
Copy and paste this URL into your WordPress site to embed
Copy and paste this code into your site to embed
